157 related articles for article (PubMed ID: 20526106)
21. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
22. New strategies for treatment of KRAS mutant metastatic colorectal cancer.
Prenen H; Tejpar S; Van Cutsem E
Clin Cancer Res; 2010 Jun; 16(11):2921-6. PubMed ID: 20460490
[TBL] [Abstract][Full Text] [Related]
23. Novel targets for anticancer treatment development in colorectal cancer.
Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
[TBL] [Abstract][Full Text] [Related]
24. Predictive markers for colorectal cancer: current status and future prospects.
Longley DB; McDermott U; Johnston PG
Clin Colorectal Cancer; 2003 Feb; 2(4):223-30. PubMed ID: 12620141
[TBL] [Abstract][Full Text] [Related]
25. Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer.
Lee SY; Oh SC
Biomed Res Int; 2016; 2016():7590245. PubMed ID: 27127793
[TBL] [Abstract][Full Text] [Related]
26. Translation initiation in colorectal cancer.
Parsyan A; Hernández G; Meterissian S
Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
[TBL] [Abstract][Full Text] [Related]
27. Regorafenib: from bench to bedside in colorectal cancer.
Shahda S; Saif MW
Expert Rev Clin Pharmacol; 2013 May; 6(3):243-8. PubMed ID: 23656338
[TBL] [Abstract][Full Text] [Related]
28. Search for novel target molecules for the effective treatment or prevention of colorectal cancer.
Tsujii M
Digestion; 2012; 85(2):99-102. PubMed ID: 22269287
[TBL] [Abstract][Full Text] [Related]
29. The impact of targeted therapy on the treatment of colorectal cancer.
Marshall JL; Hwang J
Oncology (Williston Park); 2005 Nov; 19(13 Suppl 6):19-24. PubMed ID: 16502666
[TBL] [Abstract][Full Text] [Related]
30. [Metastatic colorectal cancers and targeted therapy against EGFR].
Viret F; Gonçalves A
Med Sci (Paris); 2009 Mar; 25 Spec No 1():13-21. PubMed ID: 19361405
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!
Stintzing S; Lenz HJ
Expert Opin Pharmacother; 2013 Nov; 14(16):2203-20. PubMed ID: 23941461
[TBL] [Abstract][Full Text] [Related]
32. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
Liu X; Ji Q; Fan Z; Li Q
Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment.
Roukos DH; Katsios C; Liakakos T
Expert Rev Mol Diagn; 2010 Jul; 10(5):541-5. PubMed ID: 20629500
[No Abstract] [Full Text] [Related]
34. Biomarker-based selection of therapy for colorectal cancer.
Ross JS
Biomark Med; 2011 Jun; 5(3):319-32. PubMed ID: 21657841
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
Al Bitar S; El-Sabban M; Doughan S; Abou-Kheir W
World J Gastroenterol; 2023 Mar; 29(9):1395-1426. PubMed ID: 36998426
[TBL] [Abstract][Full Text] [Related]
36. Novel drug discovery opportunities for colorectal cancer.
Curtin JC
Expert Opin Drug Discov; 2013 Sep; 8(9):1153-64. PubMed ID: 23768167
[TBL] [Abstract][Full Text] [Related]
37. Optimal management of metastatic colorectal cancer: current status.
McRee AJ; Goldberg RM
Drugs; 2011 May; 71(7):869-84. PubMed ID: 21568364
[TBL] [Abstract][Full Text] [Related]
38. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
[TBL] [Abstract][Full Text] [Related]
39. Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapy.
Goldberg RM
Onkologie; 2005 Jun; 28(6-7):311-2. PubMed ID: 15933417
[No Abstract] [Full Text] [Related]
40. Metastatic colorectal cancer-past, progress and future.
Field K; Lipton L
World J Gastroenterol; 2007 Jul; 13(28):3806-15. PubMed ID: 17657834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
